Brief: Compugroup Medical - Final Regulatory Approval For Voluntary Public Takeover Offer - Strategic Partnership Between CVC And Compugroup Medical Takes Effect Upon Completion Of Offer
April 17 (Reuters) - COMPUGROUP MEDICAL SE & CO KGAA COP1n.DE: FINAL REGULATORY APPROVAL FOR VOLUNTARY PUBLIC TAKEOVER OFFER - STRATEGIC PARTNERSHIP BETWEEN CVC AND COMPUGROUP MEDICAL TAKES EFFECT UPON COMPLETION OF OFFER ALL OFFER CONDITIONS FULFILLED THROUGH REGULATORY APPROVALS DELISTING OFFER PLANNED SHORTLY – NO INCREASE OVER TENDER OFFER PRICE EXPECTED COMPLETION OF OFFER WILL TAKE PLACE WITHIN NEXT EIGHT BANKING DAYS SHAREHOLDERS OF COMPUGROUP MEDICAL WHO TENDERED THEIR SHARES IN THE PUBLIC TAKEOVER OFFER WILL BE PAID THE OFFER PRICE OF EUR 22.00 PER SHARE Further company coverage: [COP1n.DE] (Gdansk Newsroom) (((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on CompuGroup Medical SE & Co KgaA
See all newsBrief: Nagarro to replace CompuGroup in Germany's TecDax, Stratec in SDAX
Brief: Compugroup Medical Delisting Effective 24 June 2025
Brief: Compugroup Medical SE & Co KGaA - Issues Joint Reasoned Statement Recommending Shareholders To Accept Cvc's Public Delisting Offer
Brief: Cvc Capital Partners - Acceptance Period For Public Delisting Offer To Shareholders Of Compugroup Begins
Brief: Caesar Bidco Says Intends To Offer Cash Consideration In Amount Of Eur 22.00 Per CompuGroup Medical Share